Back to
SEI Investments Co.
AXSM
Showing 8 of 30 quarters
Position history for
SEI Investments Co.'s holdings in Axsome Therapeutics, Inc.
Yes. SEI Investments holds 76,462 shares of AXSM (Axsome Therapeutics), worth $18.7M, as of its Q2 2026 13F filing. It increased the position by 6,398 shares (+9.1%) from Q1 2026. SEI Investments has held AXSM since Q1 2019, across 30 quarterly 13F filings.
Current Value
$18.7M
Current Shares
76,462
Total Value Change
+$14.4M
Total Shares Change
+28,101
Quarter-by-Quarter History